- The FDA approves Tandem Diabetes Care's (NASDAQ:TNDM) t:slim Insulin Pump for use in children as young as six years old. The previous age limit was 12 years.
- The expanded pediatric indication does not require any changes to the existing user interface, which has the look and feel of a typical consumer device.
Tandem's t:slim insulin pump approved for kids as young as six years old
This was corrected on 02/05/2019 at 11:02 AM. Expanded pediatric indication only applies to the t:slim.
Recommended For You
More Trending News
About TNDM Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TNDM | - | - |
Tandem Diabetes Care, Inc. |